NiQuitin system transdermalny

The NiQuitin transdermal patch is used to relieve withdrawal symptoms following nicotine withdrawal associated with smoking cessation. The preparation is in the form of pink patches glued to the skin. The product contains nicotine as an active ingredient and is available without a prescription.

NiQuitin, NiQuitin Transparent (GlaxoSmithKline Consumer Healthcare)

NiQuitin transdermal patch – indications and dosage

The NiQuitin transdermal patch is the agent recommended for the relief of nicotine withdrawal symptoms associated with smoking cessation.

Dosage of the preparation

The NiQuitin transdermal patch is a patch to be applied to the skin. They should be applied to hairless, clean, dry and healthy skin. Before starting the treatment, smoking should be stopped. Apply the patch once a day, always at the same time, preferably right after waking up. The preparation should not be used for more than 1 weeks.

1. People who smoke more than 10 cigarettes a day: 0,021 g / d patch for 6 weeks, then 0,014 g / d patch for 2 weeks, then 0,007 g / d patch for 2 weeks.
2. People who smoke up to 10 cigarettes a day: a patch of 0,014 g / d for 6 weeks, then a patch of 0,007 g / d for 2 weeks.

NiQuitin transdermal patch and contraindications

Contraindications to the treatment with NiQuitin transdermal system are:

1. allergy to any ingredient of the preparation,
2. a recent heart attack,
3. unstable angina,
4. dławica Prinzmetala,
5. severe heart rhythm disorders,
6. recent ischemic stroke,
7. use in children and non-smokers or smokers very rarely.

NiQuitin transdermal patch – warnings

1. In case of cardiovascular diseases (e.g. angina, heart failure, uncontrolled hypertension, vasoconstriction diseases, severe peripheral vascular diseases, cerebral circulation disorders); atopic dermatitis or eczema (due to local hypersensitivity to the patch); gastric or duodenal ulcer; overactive thyroid gland; diabetes; pheochromocytoma of the adrenal gland; Severe liver or kidney failure should be taken with caution and see a doctor before use.
2. Smoking and using other nicotine-containing preparations should be completely stopped while using NiQuitin transdermal patch.
3. The dose should be reduced or treatment discontinued if clinically significant circulatory disturbances or other nicotine-related undesirable effects occur.
4. A doctor should be consulted and the treatment should be discontinued in the event of severe or prolonged skin reactions. People with a contact allergy to NiQuitin patches should be aware that they may develop a severe allergic reaction through exposure to other nicotine-containing products or after smoking a cigarette.
5. Avoid contact of the patch with your eyes and nose, and wash your hands with soap-free water after each use, as soap may increase nicotine absorption.
6. The dose of nicotine in used or new patches may be dangerous for children. Keep the product out of the reach of children and carefully dispose of the used patches.
7. It is not recommended to use patches for more than 10 weeks. Long-term use of nicotine can be toxic and addictive.
8. Pregnant women and women trying to conceive should try to quit without the help of nicotine replacement therapy. If this attempt is unsuccessful, before using the preparation during pregnancy or breastfeeding, it is absolutely necessary to consult a doctor who will assess the risk-benefit ratio.
9. Nicotine taken in any form during pregnancy and breastfeeding has a detrimental effect on both the mother and the baby.
10. There is no information on the effects of NiQuitin transdermal patch on the ability to drive and use machines

NiQuitin transdermal patch with other medications

1. Inform your doctor about all medications you have recently taken, including those obtained without a prescription.
2. Quitting smoking with or without nicotine replacement therapy may be a reason to change the dosage of some medications you are taking.
3. Consult your doctor before using NiQuitin transdermal patch if you are taking medicines such as: imipramine, clomipramine, fluvoxamine (medicines for depression); clozapine, olanzapine (medicines for schizophrenia); theophylline (a medicine used in bronchial asthma, chronic obstructive pulmonary disease and bronchitis); flecainide; pentazocine, phenylbutazone, tacrine, caffeine, phenacetin, insulin, adrenergic blockers (prazosin, propranolol), drugs that activate adrenergic receptors (isoprenaline, salbutamol).

NiQuitin transdermal patch – side effects

Treatment with NiQuitin transdermal patch may cause the following side effects:

1. itching
2. local skin reactions,
3. problems with sleeping,
4. nervousness,
5. headaches and dizziness,
6. feeling of discomfort
7. tremors
8. dyspnoea,
9. pharyngitis,
10. cough,
11. constipation
12. increased sweating,
13. joint and / or muscle pain,
14. flu-like symptoms
15. weakness,
16. tiredness,
17. nausea,
18. vomiting,
19. erythema,
20. hives
21. palpitations
22. fast heart beat
23. very rarely allergic or contact dermatitis.

Some of the symptoms listed above may be caused by stopping smoking.